Systems and methods for identifying unknown drug targets via adverse event data
First Claim
1. A method for building a molecular entity model comprising unknown drug target interactions identified via adverse event data, comprising:
- receiving, by an analyzer module executed by a processor of a computing device from a user, an identification of a first drug having one or more unknown target proteins;
identifying, by the analyzer module from a medication information database stored in a computer-readable storage medium, a second drug related to the first drug;
retrieving, by the analyzer module from an adverse event database representing physiological reactions from interaction of molecular entities with pharmaceutical compounds of drugs stored in the computer-readable storage medium, a first side effect profile associated with the first drug, and a second side effect profile associated with the second drug;
generating, by the analyzer module, a third side effect profile comprising a subset of the first side effect profile not shared by the second side effect profile;
identifying, by the analyzer module from the adverse event database, a third drug having a fourth side effect profile comprising the third side effect profile;
retrieving, by the analyzer module from the medication information database, one or more target proteins of the third drug not targeted by the second drug; and
building, by the analyzer module, a molecular entity model with the retrieved one or more target proteins as potential target proteins of the first drug.
3 Assignments
0 Petitions
Accused Products
Abstract
The present disclosure is directed to systems and methods for identifying unknown drug targets via adverse event data. An analyzer receives an identification of a first drug having one or more unknown target proteins and identifies a second drug related to the first drug. The analyzer retrieves, from an adverse event database, a first side effect profile associated with the first drug, and a second side effect profile associated with the second drug. The analyzer generates a third side effect profile including a subset of the first side effect profile not shared by the second side effect profile, and identifies a third drug having a fourth side effect profile including the third side effect profile. The analyzer retrieves a list of one or more target proteins of the third drug not targeted by the second drug, and presents the retrieved list as potential target proteins of the first drug.
-
Citations
18 Claims
-
1. A method for building a molecular entity model comprising unknown drug target interactions identified via adverse event data, comprising:
-
receiving, by an analyzer module executed by a processor of a computing device from a user, an identification of a first drug having one or more unknown target proteins; identifying, by the analyzer module from a medication information database stored in a computer-readable storage medium, a second drug related to the first drug; retrieving, by the analyzer module from an adverse event database representing physiological reactions from interaction of molecular entities with pharmaceutical compounds of drugs stored in the computer-readable storage medium, a first side effect profile associated with the first drug, and a second side effect profile associated with the second drug; generating, by the analyzer module, a third side effect profile comprising a subset of the first side effect profile not shared by the second side effect profile; identifying, by the analyzer module from the adverse event database, a third drug having a fourth side effect profile comprising the third side effect profile; retrieving, by the analyzer module from the medication information database, one or more target proteins of the third drug not targeted by the second drug; and building, by the analyzer module, a molecular entity model with the retrieved one or more target proteins as potential target proteins of the first drug. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
-
10. A system for building a molecular entity model comprising unknown drug target interactions identified via adverse event data, comprising:
-
a computing device, in communication with a computer-readable storage medium comprising an adverse event database representing physiological reactions from interaction of molecular entities with pharmaceutical compounds of drugs and a medication information database, comprising a display interface and a processor executing an analyzer module configured for; receiving, from a user, an identification of a first drug having one or more unknown target proteins; identifying, from the medication information database, a second drug related to the first drug; retrieving, from the adverse event database, a first side effect profile associated with the first drug, and a second side effect profile associated with the second drug; generating a third side effect profile comprising a subset of the first side effect profile not shared by the second side effect profile; identifying, from the adverse event database, a third drug having a fourth side effect profile comprising the third side effect profile; retrieving, from the medication information database, a list of one or more target proteins of the third drug not targeted by the second drug; and building a molecular entity model with the retrieved one or more target proteins as potential target proteins of the first drug. - View Dependent Claims (11, 12, 13, 14, 15, 16, 17, 18)
-
Specification